C2i Genomics Raises $100 Million To Commercialize the Detection of Tiny Traces of Cancer Using AI and Whole Genome Sequencing
Similar Posts
Leal Health Launches New AI Feature to Simplify Interpretation of Genetic Testing and Provide Minorities Increased Access to Clinical Trial and Cancer Treatments
Results Highlighting Racial Disparities in Genetic Testing and Interpreting Results Presented at 2023 ASCO Annual Meeting. Data Shows that…
Massachusetts’ Lawrence General to Deploy Expanse
Integration and clinical sophistication of Expanse named as key reasons why Lawrence selected MEDITECH After a competitive Enterprise Health…
AvaSure launches new AI capabilities, teams up with Kinometrix
Virtual care leader unveils AI enhancements to AvaSure TeleSitter solution and partnership with Kinometrix, a predictive analytics platform, for…
Teladoc Joins Health IT Now Steering Committee
Health IT Now confirmed to MHW this week that it has a new Steering Committee member, Teladoc, Inc. “We…
